Dianthus Therapeutics to Participate in Four Investor Conferences During November

Core Insights - Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing next-generation therapies for severe autoimmune diseases [3] Company Participation in Conferences - The company will participate in four upcoming investor conferences, with CEO Marino Garcia hosting fireside chats and one-on-one investor meetings [1] - The specific conferences include: - Guggenheim 2nd Annual Healthcare Innovation Conference on November 11, 2025 - TD Cowen Immunology & Inflammation Summit on November 12, 2025 - Stifel 2025 Healthcare Conference on November 13, 2025 - Jefferies Global Healthcare Conference on November 17, 2025 [4] Company Overview - Dianthus Therapeutics is based in New York City and Waltham, Massachusetts, and is led by an experienced team of biotech and pharma executives [3] - The company's mission is to deliver transformative medicines for individuals suffering from severe autoimmune and inflammatory diseases [3]